№ p / p
|
Service code
|
The name of the service in accordance with the nomenclature of medical services (pr. MZ RF dated 13.10.17 No. 804n)
|
Note
|
unit of measurement
|
Service cost
|
1
|
B01.054.001
|
Examination (consultation) by a physiotherapist
|
specialist doctor
|
1 service
|
350,00
|
2
|
B01.054.001
|
Examination (consultation) by a physiotherapist
|
department head
|
1 service
|
400.00
|
3
|
А22.01.006
|
Ultraviolet irradiation of the skin
|
|
1 service
|
270,00
|
4
|
А22.04.004
|
Ultraviolet radiation for joint diseases
|
|
1 service
|
270,00
|
5
|
А22.23.002
|
Ultraviolet irradiation for diseases of the central nervous system and brain
|
|
1 service
|
270,00
|
6
|
А22.30.007
|
Exposure to integral ultraviolet radiation
|
|
1 service
|
270,00
|
7
|
А22.30.014
|
Determination of biodose for ultraviolet irradiation
|
|
1 service
|
270,00
|
8
|
A20.30.023
|
Thermal action
|
|
1 service
|
370.00
|
9
|
А17.08.001.001
|
Endonasal electrophoresis of drugs
|
|
1 service
|
370.00
|
10
|
A17.25.001
|
Intra-aural electrophoresis of drugs for diseases of the organ of hearing
|
|
1 service
|
370.00
|
11
|
A17.03.001
|
Electrophoresis of drugs for bone pathology
|
|
1 service
|
310,00
|
12
|
А17.08.001
|
Electrophoresis of drugs for diseases of the upper respiratory tract
|
|
1 service
|
310,00
|
13
|
A17.09.001
|
Electrophoresis of drugs for lung pathology
|
|
1 service
|
310,00
|
14
|
A17.12.001
|
Electrophoresis for diseases of large blood vessels
|
|
1 service
|
310,00
|
15
|
A17.13.001
|
Electrophoresis of drugs for microcirculation disorders
|
|
1 service
|
310,00
|
16
|
А17.14.001
|
Electrophoresis of drugs for diseases of the liver and biliary tract
|
|
1 service
|
310,00
|
17
|
А17.15.001
|
Electrophoresis of drugs for diseases of the pancreas
|
|
1 service
|
310,00
|
18
|
А17.16.001
|
Electrophoresis of drugs for diseases of the stomach and duodenum
|
|
1 service
|
310,00
|
19
|
A17.19.001
|
Electrophoresis of drugs for bowel diseases
|
|
1 service
|
310,00
|
20
|
A17.20.002
|
Electrophoresis of drugs for diseases of the female genital organs
|
|
1 service
|
310,00
|
21
|
A17.21.001
|
Electrophoresis of drugs for diseases of the male genital organs
|
|
1 service
|
310,00
|
22
|
A17.22.001
|
Electrophoresis of drugs for diseases of the endocrine glands
|
|
1 service
|
310,00
|
23
|
A17.23.001
|
Electrophoresis of drugs for diseases of the central nervous system and brain
|
|
1 service
|
310,00
|
24
|
A17.24.005
|
Electrophoresis of drugs for diseases of the peripheral nervous system
|
|
1 service
|
310,00
|
25
|
A17.26.001
|
Electrophoresis of drugs for diseases of the organ of vision
|
|
1 service
|
310,00
|
26
|
A17.28.001
|
Electrophoresis of drugs for kidney disease
|
|
1 service
|
310,00
|
27
|
A17.24.002
|
Galvanization for diseases of the peripheral nervous system
|
|
1 service
|
300,00
|
28
|
A17.26.005
|
Galvanization for diseases of the organ of vision
|
|
1 service
|
300,00
|
29
|
A17.30.24.001
|
Diadynamic current electrophoresis (DCT-phoresis)
|
|
1 service
|
360,00
|
30
|
A17.30.24.002
|
Electrophoresis with sinusoidal modulated currents (CMT-phoresis)
|
|
1 service
|
360,00
|
31
|
A17.01.012
|
Exposure to diadynamic currents (DDT-therapy) in diseases of the skin and subcutaneous fat
|
|
1 service
|
340,00
|
32
|
A17.01.013
|
Exposure to sinusoidal modulated currents (CMT therapy) for diseases of the skin and subcutaneous fat
|
|
1 service
|
340,00
|
33
|
A17.03.002
|
Exposure to diadynamic currents (DDT-therapy) in bone pathology
|
|
1 service
|
340,00
|
34
|
A17.03.003
|
Exposure to sinusoidal modulated currents (CMT therapy) in bone pathology
|
|
1 service
|
340,00
|
35
|
A17.10.001.001
|
Exposure to sinusoidal modulated currents (CMT therapy) in cardiac and pericardial pathology
|
|
1 service
|
340,00
|
36
|
A17.13.002
|
Exposure to sinusoidal modulated currents (CMT therapy) for microcirculation disorders
|
|
1 service
|
340,00
|
37
|
A17.24.003
|
Bernard currents for diseases of the peripheral nervous system
|
|
1 service
|
340,00
|
38
|
A17.24.007
|
Exposure to sinusoidal modulated currents (CMT therapy) in diseases of the peripheral nervous system
|
|
1 service
|
340,00
|
39
|
А17.30.003
|
Diadynamotherapy
|
|
1 service
|
340,00
|
40
|
A17.30.004
|
Exposure to sinusoidal modulated currents
|
|
1 service
|
340,00
|
41
|
A17.30.005
|
Exposure to interference currents
|
|
1 service
|
370.00
|
42
|
A17.01.014
|
Interference therapy for diseases of the skin and subcutaneous fat
|
|
1 service
|
340,00
|
43
|
A17.10.001.002
|
Interference therapy for cardiac and pericardial pathology
|
|
1 service
|
340,00
|
44
|
A17.29.002
|
Electrosleep
|
|
1 service
|
400.00
|
45
|
A17.01.007
|
Darsonvalization of the skin
|
|
1 service
|
350,00
|
46
|
A17.05.001
|
Local darsonvalization for diseases of the hematopoietic system and blood
|
|
1 service
|
350,00
|
47
|
A17.08.002
|
Darsonvalization for diseases of the upper respiratory tract
|
|
1 service
|
350,00
|
48
|
A17.10.003
|
Darsonvalization in cardiac and pericardial pathology
|
|
1 service
|
350,00
|
49
|
A17.12.002
|
Local darsonvalization in diseases of large blood vessels
|
|
1 service
|
350,00
|
50
|
A17.13.004
|
Darsonvalization for microcirculation disorders
|
|
1 service
|
350,00
|
51
|
A17.20.05
|
Local darsonvalization for diseases of the female genital organs
|
|
1 service
|
350,00
|
52
|
A17.23.002
|
Local darsonvalization for diseases of the central nervous system and brain
|
|
1 service
|
350,00
|
53
|
A17.24.004
|
Local darsonvalization in diseases of the peripheral nervous system
|
|
1 service
|
350,00
|
54
|
A17.25.002
|
Darsonvalization of the organ of hearing
|
|
1 service
|
350,00
|
55
|
A17.25.05
|
Endouralization darsonvalization for diseases of the organ of hearing
|
|
1 service
|
350,00
|
56
|
A17.01.008
|
Exposure to ultra-high frequency currents on the skin
|
|
1 service
|
350,00
|
57
|
A17.03.006
|
Exposure to ultra-high frequency currents in bone pathology
|
|
1 service
|
350,00
|
58
|
А17.07.011
|
Exposure to ultra-high frequency currents in pathology of the oral cavity and teeth
|
|
1 service
|
350,00
|
59
|
A17.09.004
|
Exposure to ultra-high frequency currents in diseases of the lower respiratory tract
|
|
1 service
|
350,00
|
60
|
A17.08.004
|
Exposure to ultra-high frequency currents in diseases of the upper respiratory tract
|
|
1 service
|
350,00
|
61
|
А17.23.006
|
Transcerebral exposure to ultra-high frequency currents
|
|
1 service
|
350,00
|
62
|
A17.26.06
|
Exposure to ultra-high frequency currents in diseases of the organ of vision
|
|
1 service
|
350,00
|
63
|
A17.30.017
|
Exposure to an ultra-high frequency electric field (UHF EF)
|
|
1 service
|
350,00
|
64
|
A17.009.005
|
High-frequency magnetotherapy - inductothermy for diseases of the lower respiratory tract
|
|
1 service
|
350,00
|
65
|
A17.28.004
|
High-frequency magnetotherapy - inductothermy for kidney and urinary tract diseases
|
|
1 service
|
350,00
|
66
|
A17.30.016
|
Exposure to high-frequency electromagnetic fields (inductothermy)
|
|
1 service
|
350,00
|
67
|
A17.30.018
|
Exposure to electromagnetic radiation in the decimeter range (UHF)
|
|
1 service
|
340,00
|
68
|
A17.02.001
|
Muscle electrical stimulation
|
|
1 service
|
350,00
|
69
|
A17.28.002
|
Electrical stimulation of the ureters in diseases of the kidneys and urinary tract
|
|
1 service
|
350,00
|
70
|
A17.28.003
|
Bladder electrical stimulation
|
|
1 service
|
350,00
|
71
|
A17.30.030
|
Electrical stimulation of the facial and / or trigeminal nerves, facial and / or masticatory muscles
|
|
1 service
|
350,00
|
72
|
A17.24.011
|
Electrostimulation of motor nerves
|
|
1 service
|
350,00
|
73
|
A17.30.034
|
Phonophoresis drug
|
|
1 service
|
320,00
|
74
|
А22.01.001
|
Ultrasound Skin Treatment
|
|
1 service
|
320,00
|
75
|
А22.01.001.001
|
Phonophoresis medicinal skin
|
|
1 service
|
320,00
|
76
|
А22.02.002
|
Phonophoresis drug for muscle diseases
|
|
1 service
|
320,00
|
77
|
А22.04.002
|
Exposure to ultrasound for joint diseases
|
|
1 service
|
320,00
|
78
|
А22.04.002.001
|
Phonophoresis drug for joint diseases
|
|
1 service
|
320,00
|
79
|
А22.08.002
|
Exposure to ultrasound for upper respiratory tract diseases
|
|
1 service
|
320,00
|
80
|
А22.08.005
|
Phonophoresis drug for diseases of the upper respiratory tract
|
|
1 service
|
320,00
|
81
|
А22.09.008
|
Drug ultraphonophoresis for diseases of the lower respiratory tract
|
|
1 service
|
320,00
|
82
|
А22.12.002
|
Exposure to ultrasound for diseases of large blood vessels
|
|
1 service
|
320,00
|
83
|
А22.12.002.002
|
Phonophoresis drug for diseases of large blood vessels
|
|
1 service
|
320,00
|
84
|
А22.14.002
|
Exposure to ultrasound for liver and biliary tract diseases
|
|
1 service
|
320,00
|
85
|
A22.14.002.001
|
Ultraphonophoresis drug for diseases of the liver and biliary tract
|
|
1 service
|
320,00
|
86
|
A22.22.002
|
Exposure to ultrasound in diseases of the endocrine glands
|
|
1 service
|
320,00
|
87
|
A22.22.002.001
|
Medicinal phonophoresis for diseases of the endocrine glands
|
|
1 service
|
320,00
|
88
|
А22.23.003
|
Exposure to ultrasound in diseases of the central nervous system and brain
|
|
1 service
|
320,00
|
89
|
A22.23.003.001
|
Medicinal phonophoresis for diseases of the central nervous system and brain
|
|
1 service
|
320,00
|
90
|
А22.24.002
|
Exposure to ultrasound in diseases of the peripheral nervous system
|
|
1 service
|
320,00
|
91
|
A22.24.002.001
|
Medicinal phonophoresis for diseases of the peripheral nervous system
|
|
1 service
|
320,00
|
92
|
A22.26.025
|
Exposure to ultrasound for diseases of the organs of vision
|
|
1 service
|
320,00
|
93
|
А22.28.003
|
Exposure to ultrasound in diseases of the kidneys and urinary tract
|
|
1 service
|
320,00
|
94
|
A17.03.007
|
Exposure to magnetic fields in bone pathology
|
|
1 service
|
370.00
|
95
|
А17.07.013
|
Exposure to magnetic fields in pathology of the oral cavity and teeth
|
|
1 service
|
370.00
|
96
|
А17.13.005
|
Exposure to magnetic fields in case of microcirculation disorders
|
|
1 service
|
370.00
|
97
|
A17.20.001
|
Alternating magnetic field in diseases of the female genital organs
|
|
1 service
|
370.00
|
98
|
A17.24.009
|
Exposure to magnetic fields in diseases of the peripheral nervous system
|
|
1 service
|
340,00
|
99
|
A17.26.002
|
Low-frequency magnetotherapy for the organ of vision
|
|
1 service
|
340,00
|
100
|
A17.30.019
|
Exposure to an alternating magnetic field (ACF)
|
|
1 service
|
340,00
|
101
|
A17.30.019.001
|
Exposure to magnetic fields for muscle diseases
|
|
1 service
|
350,00
|
102
|
A17.30.025
|
General magnetotherapy
|
|
1 service
|
340,00
|
103
|
A17.30.031
|
Exposure to magnetic fields
|
|
1 service
|
350,00
|
104
|
А22.01.005
|
Low-intensity laser skin irradiation
|
|
1 service
|
350,00
|
105
|
А22.02.001
|
Exposure to low-intensity laser radiation for muscle diseases
|
|
1 service
|
350,00
|
106
|
А22.04.003
|
Exposure to low-intensity laser radiation for joint diseases
|
|
1 service
|
350,00
|
107
|
А22.08.007
|
Exposure to low-intensity laser radiation for upper respiratory tract diseases
|
|
1 service
|
350,00
|
108
|
А22.09.010
|
Exposure to low-intensity laser radiation for diseases of the lower respiratory tract
|
|
1 service
|
350,00
|
109
|
А22.10.001
|
Exposure to low-intensity laser radiation in diseases of the heart and pericardium
|
|
1 service
|
350,00
|
110
|
А22.12.001
|
Exposure to low-intensity laser radiation in diseases of large blood vessels
|
|
1 service
|
350,00
|
111
|
А22.14.003
|
Exposure to low-intensity laser radiation in diseases of the liver and biliary tract
|
|
1 service
|
350,00
|
112
|
А22.20.001
|
Laser therapy for diseases of the female genital organs
|
|
1 service
|
350,00
|
113
|
А22.22.001
|
Exposure to low-intensity laser radiation in diseases of the endocrine glands
|
|
1 service
|
350,00
|
114
|
А22.23.001
|
Exposure to low-intensity laser radiation in diseases of the central nervous system and brain
|
|
1 service
|
350,00
|
115
|
А22.24.001
|
Exposure to low-intensity laser radiation in diseases of the peripheral nervous system
|
|
1 service
|
340,00
|
116
|
A17.30.027
|
Lasertophoresis
|
|
1 service
|
370.00
|
117
|
A17.01.002
|
Impact on acupuncture points by other physical factors
|
|
1 service
|
340,00
|
118
|
А20.24.002
|
Paraffin therapy for diseases of the peripheral nervous system
|
|
1 service
|
420,00
|
119
|
А20.03.002
|
Exposure to paraffin in diseases of the skeletal system
|
|
1 service
|
420,00
|
120
|
А20.09.004
|
Exposure to paraffin (ozokerite) in diseases of the lower respiratory tract and lung tissue
|
|
1 service
|
420,00
|
121
|
А20.14.003
|
Exposure to paraffin (ozokerite) in diseases of the liver and biliary tract
|
|
1 service
|
420,00
|
122
|
А20.28.002
|
Exposure to paraffin for kidney and urinary tract diseases
|
|
1 service
|
420,00
|
123
|
А20.15.003
|
Exposure to paraffin (ozokerite) in diseases of the pancreas
|
|
1 service
|
420,00
|
124
|
A20.16.003
|
Exposure to paraffin (ozokerite) in diseases of the esophagus, stomach, duodenum
|
|
1 service
|
420,00
|
125
|
A20.20.002
|
Exposure to paraffin (ozokerite) in diseases of the female genital organs
|
|
1 service
|
420,00
|
126
|
А20.21.002
|
Exposure to paraffin (ozokerite) in diseases of the male genital organs
|
|
1 service
|
420,00
|
127
|
А20.23.002
|
Exposure to paraffin (ozokerite) in diseases of the central nervous system
|
|
1 service
|
420,00
|
128
|
A20.30.006
|
Medicinal medicinal baths
|
|
1 service
|
240,00
|
129
|
A20.03.001
|
Exposure to therapeutic mud for diseases of the skeletal system
|
|
1 service
|
450,00
|
130
|
А20.09.003
|
Exposure to therapeutic mud for diseases of the lower respiratory tract and lung tissue
|
|
1 service
|
450,00
|
131
|
А20.14.002
|
Exposure to therapeutic mud for diseases of the liver and biliary tract
|
|
1 service
|
450,00
|
132
|
А20.15.002
|
Exposure to therapeutic mud for diseases of the pancreas
|
|
1 service
|
450,00
|
133
|
А20.28.001
|
Mud therapy for kidney and urinary tract diseases
|
|
1 service
|
450,00
|
134
|
A20.16.002
|
Exposure to therapeutic mud for diseases of the esophagus, stomach, duodenum
|
|
1 service
|
450,00
|
135
|
A20.20.001
|
Exposure to therapeutic mud for diseases of the female genital organs
|
|
1 service
|
450,00
|
136
|
А20.21.001
|
Exposure to therapeutic mud for diseases of the male genital organs
|
|
1 service
|
450,00
|
137
|
A20.23.001
|
Exposure to therapeutic mud for diseases of the central nervous system and the brain (ozokerite)
|
|
1 service
|
450,00
|
138
|
А20.24.001
|
Mud therapy of diseases of the peripheral nervous system
|
|
1 service
|
600.00
|
139
|
A20.30.019
|
Aerial impact
|
|
1 service
|
320,00
|
140
|
A20.30.010
|
Underwater shower-massage therapeutic
|
|
1 service
|
550,00
|
141
|
A17.30.008
|
Exposure to electromagnetic radiation of the millimeter range (EHF-therapy)
|
|
1 service
|
260,00
|
142
|
A17.01.002.004
|
Acupuncture with extremely high frequency currents (EHF-puncture)
|
|
1 service
|
260,00
|
143
|
A20.30.031
|
Gas baths (oxygen, carbon dioxide, nitrogen)
|
carbonic
|
1 service
|
330,00
|
144
|
А24.01.005.001
|
General cryotherapy (cryochamber)
|
|
1 service
|
650.00
|
145
|
A17.30.011
|
Mesodiencephalic modulation
|
|
1 service
|
500.00
|
146
|
A19.03.001.009
|
Mechanotherapy on mechanotherapy devices with an electric drive for spinal injury
|
apparatus "Ormed"
|
1 service
|
250.00
|
147
|
A20.30.030
|
Air bubble baths (pearl)
|
|
1 service
|
280,00
|
148
|
A20.30.011
|
Healing shower
|
rising shower
|
1 service
|
210.00
|
149
|
А22.30.001
|
Infrared exposure
|
apparatus "Tera-Fot"
|
1 service
|
300,00
|
150
|
А24.01.005.002
|
Local contact hypothermia
|
|
1 service
|
300,00
|
151
|
A20.30.011
|
Healing shower
|
shower Charcot
|
1 service
|
400.00
|
152
|
A20.30.011
|
Healing shower
|
circular shower
|
1 service
|
250.00
|
153
|
A17.30.009
|
Barometric influence - pressotherapy of extremities, pneumocompression
|
|
1 service
|
310,00
|
154
|
A17.30.026
|
Infitherapy
|
|
1 service
|
300,00
|
155
|
A 20.30.006
|
Medicinal medicinal baths
|
Rehabilitation therapy (using sika deer pantohematogen)
|
1 service
|
970,00
|
156
|
A 20.30.006
|
Medicinal medicinal baths
|
Prevention (using sika deer pantohematogen)
|
1 service
|
610.00
|